- EQS-Adhoc: BB Biotech AG publishes its interim report and announces a new head of its investment management team
- EQS-News: Substantial pipeline progress at several portfolio companies offsets rate-related market volatility
- EQS-PVR: BB BIOTECH AG: Disclosure of Shareholdings
- EQS-DD: BB BIOTECH AG: Dr. Thomas von Planta, buy
Key statistics
On Friday, BB Biotech AG (BION:SWX) closed at 43.90, -11.85% below its 52-week high of 49.80, set on Feb 23, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Shares outstanding | 55.40m |
---|---|
Market cap | 2.43bn CHF |
Total assets | 2.60bn CHF |
Total expense ratio | 1.43% |
High | 43.90 |
Low | 43.20 |
Previous close | 43.45 |
Average volume | 44.59k |
---|---|
YTD Change | +2.69% |
Beta | 1.1460 |
Diluted NAV (est) | 46.95 |
Diluted NAV (last pub) | 46.95 |
Premium/Discount | -- |
Net Gearing | 0.00% |
Annual div (ADY) | 2.00 CHF |
---|---|
Annual div yield (ADY) | 4.56% |
Div ex-date | Mar 25 2024 |
Div pay-date | Mar 27 2024 |
Data delayed at least 15 minutes, as of Jul 26 2024 16:30 BST.
More ▼